癌症治疗和生存率统计,2025年
Nikita Sandeep Wagle1, Leticia Nogueira2, Theresa P Devasia3
1Cancer Surveillance Research, American Cancer Society, Atlanta, Georgia, USA.
CA: a cancer journal for clinicians
|May 30, 2025
概括
美国的癌症幸存率正在上升,到2025年,癌症幸存者将达到1860万. 癌症治疗的种族差异仍然很大,特别是肺癌和直肠癌,需要有针对性的干预措施.
科学领域:
- 公共卫生 公共卫生
- 癌症流行病学 癌症流行病学
- 健康差异 在健康上的差异
背景情况:
- 由于人口增长,老龄化以及早期检测和治疗改善的生存率,美国癌症幸存者的数量正在增加.
- 癌症患病率估计对于公共卫生规划和为不断增长的幸存者人口分配资源至关重要.
研究的目的:
- 为了估计目前和预计的美国癌症幸存者的数量.
- 确定最常见的癌症类型,并描述癌症幸存者的人口特征.
- 分析癌症治疗中的种族差异,并确定有针对性的干预领域.
主要方法:
- 利用来自监测,流行病学和最终结果 (SEER) 癌症登记处,国家卫生统计中心 (NCHS) 和美国人口普查局的数据进行流行率估计.
- 整合了来自国家癌症数据库的数据,以分析癌症治疗模式和副作用.
- 检查了各种癌症阶段和类型在治疗中的种族差异.
主要成果:
- 截至2025年1月1日,美国约有1860万人患有癌症史,预计到2035年将超过2200万.
- 最常见的癌症包括前列腺癌,皮肤黑色素瘤和结直肠癌在男性中,乳腺癌,子宫体和甲状腺癌在女性中.
- 在治疗中观察到显著的种族差异,与白人相比,黑人人不太可能接受推的治疗方法,比如肺癌的手术和直肠癌的乳腺切除术.
结论:
- 越来越多的癌症幸存者需要持续关注公共卫生和资源配置.
- 解决癌症治疗中的种族差异对于确保公平的护理和改善所有幸存者的结果至关重要.
- 有针对性的,多层次的干预措施是必不可少的,以扩大获得高质量的癌症护理和生存资源的机会,从而减少差距.
相关概念视频
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Actuarial Approach
140
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
140
Cancer
49.9K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.9K


